A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A

UC Davis Cancer Center, Sacramento, California, United States

Georgetown Uni Medical Center, Washington D.C., District of Columbia, United States

Indiana Hemophilia & Thrombosis center, Indianapolis, Indiana, United States

University of Iowa Hospitals and Clnics Dept of Pediatrics, Iowa City, Iowa, United States

British Columbia Children's Hospital, Vancouver, British Columbia, Canada

Hamilton Health Sciences Corporation, Hamilton, Ontario, Canada

IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Lombardy, Italy

Istituto Clinico Humanitas, Rozzano (MI), Lombardy, Italy

Auckland Cancer Trial Centre, Auckland, New Zealand

Uniwersyteckie Centrum Kliniczne, Gda?sk, Poland

Instytut Hematologii i Transfuzjologii, Warsaw, Poland

Hospital Sant Joan de Deu, Esplugues de Llobregat, Barcelona, Spain

Hospital Universitario la Paz, Madrid, Spain

Hospital Regional Universitario Carlos Haya, Málaga, Spain